The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
The endocannabinoid system (ECS) has been placed in the anti-cancer spotlight in the last decade. The immense data load published on its dual role in both tumorigenesis and inhibition of tumor growth and metastatic spread has transformed the cannabinoid receptors CB1 (CB1R) and CB2 (CB2R), and other...
Saved in:
Main Authors: | Estefanía Moreno (Author), Milena Cavic (Author), Ana Krivokuca (Author), Vicent Casadó (Author), Enric Canela (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Evidence of Adenosine Deaminase Linking Adenosine A2A Receptor and CD26 Proteins
by: Estefanía Moreno, et al.
Published: (2018) -
Antioxidants for the Treatment of Breast Cancer: Are We There Yet?
by: Carmen Griñan-Lison, et al.
Published: (2021) -
Adenosine A2A receptors and A2A receptor heteromers as key players in striatal function
by: Sergi eFerre, et al.
Published: (2011) -
Cancer vaccines<subtitle>Are we there yet?</subtitle>
by: Michael G. Hanna, Jr
Published: (2012) -
The Role of Endocannabinoid System in Neuroprotection: Molecular Targets and Therapeutic Opportunities
by: Sonia Thapa, et al.
Published: (2023)